← All trials
NCT05768178
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2023
- Primary completion
- Oct 31, 2029
- Completion date
- Oct 31, 2029
- First posted
- Mar 14, 2023
- Last posted
- Oct 25, 2023
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cancer Research UKLead sponsor
- RocheCollaborator
- The Christie NHS Foundation TrustOverall official - principal investigator
- University of ManchesterCollaborator
- University of BirminghamCollaborator
- Royal Marsden Hospital NHS TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.